PETA Statement on What Monkey Importer Inotiv Did NOT Tell Shareholders

For Immediate Release:
January 11, 2023

Contact:
Tasgola Bruner 202-483-7382

Please see the following statement from PETA Senior Vice President Kathy Guillermo regarding Inotiv’s fiscal year 2022 report, released yesterday, and continued issues with importing monkeys for use in laboratories:

Inotiv may be in trouble with shareholders for attempting to paint a rosy picture of a dark reality: A quarter of the company’s revenue in 2022 came from imports of Cambodian monkeys, whom the International Union for Conservation of Nature listed as endangered in July 2022 and whom the CDC acknowledged as a source of a deadly pathogen. Inotiv also failed to advise its shareholders that it’s one of the currently unindicted co-conspirators in the U.S. Department of Justice lawsuit against Cambodian government officials and employees of its Cambodian monkey supplier. Industry insiders report that they can’t tell if the paperwork on imported monkeys has been falsified. If Inotiv continues to do business with this shady Cambodian monkey farm, the company assumes even more legal risk and culpability. Inotiv failed to be forthcoming with its shareholders, or reveal any steps to be taken beyond site visits, about determining which of the unsold monkeys in its custody were laundered, or commit to sending all survivors to sanctuaries. PETA recently became an Inotiv shareholder, following the company’s closure of its beagle-breeding facility, in order to monitor Inotiv’s adherence to animal protection regulations, and we will be watching closely.

For more information on PETA’s newsgathering and reporting, please visit PETA.org or follow the group on Twitter, Facebook, or Instagram.